James Maxwell, MD, Scottsdale, AZ, USA; Nicholas Theodore, MD, Phoenix, AZ, USA; Thomas Gilbert, MD, St. Louis Park, MN, USA; Bettina Willie, MS, Roy Bloebaum, PhD, Salt Lake City, UT, USA; Nathaniel R. Ordway, MS, Hansen A. Yuan, MD, Syracuse, NY, USA; Steven Griffith, PhD, Minneapolis, MN, USAIntroduction: Autograft has typically been used for interbody cage fusions of the spine with positive results. Yet, there is a need to provide alternatives to autogenous bone grafts. A potential osteopromotive growth factor is rhMP52 (also referred to as bone morphogenetic protein [BMP]-14, GDF-5 or CDMP-1) a divergent member of the BMP family. In previous animal studies, a mineralized collagen matrix (Healos Bone Graft Substitute) has been shown histologically to be replaced with mature bone when combined with autogenous bone marrow. The purpose of this study was to evaluate the combination of rhMP52 and Healos (Healos/MP52) for the promotion of spinal fusion in a baboon model using anterior lumbar threaded interbody cages. The effectiveness of Healos/MP52 to produce spinal fusion in and around interbody cages was compared with autogenous iliac crest bone graft.Materials and methods: In each of eight mature baboons (Papio cynocephalus), two noncontiguous spinal motion segments, L3–L4 and L5–L6, were implanted with single-threaded cages (Sulzer Spinetech, Minneapolis MN) that were randomly filled with either autograft or Healos/MP52 (Orquest, Mountainview, CA). Radiographs were obtained immediately after surgery and at 3-month intervals until animals were killed at either 3 months (n=4) or 6 months (n=4). After removing the spines en bloc, quantitative computed tomography was performed in a blinded manner within each cage chamber on mid-disc axial images. Individual motion segments were tested for biomechanical stability (ie, stiffness and range of motion) nondestructively in axial compression (300 N), flexion-extension (+4.5 Nm), lateral bending (+3 Nm) and torsion (+4.5 Nm). Histologic evaluation included mid-sagittal undecalcified sectioning, microradiography, backscattered electron microscopy, histomorphometry, light microscopy and pathoanatomic evaluation performed by blinded, independent examiners. Fusion was evaluated by a consensus of independent reviewers on lateral radiographs and histologic consideration with a definition of bridging trabecular bone from one end plate to the other through the holes of the cage.Results: There were no neurologic injuries or complications associated with surgery. No systemic effects were detected at necropsy. There was no evidence of bony compromise within the spinal canal or of delayed neurologic dysfunction. There were no instances of hardware failure. In six of eight animals (75%), a preponderance of observers judged the Healos/MP52 level to exhibit a more robust bone growth response than the autograft level. Lateral radiographs of cages filled with Healos/MP52 showed evidence of bone growth and anterior bony bridging outside of the implant that often became fully consolidated by 6 months. Radiographic fusion success for Healos/MP52 was 33.3% and 58.3% at 3 and 6 months, respectively. In contrast, the autograft-filled cages demonstrated 25% fusion success at both time points. A time-dependent difference in computed tomography (CT) densitometry was demonstrated in the Healos/MP52 group: 386.0 + 121.8 HU versus 568.6 + 191.6 HU, for 3 and 6 months, respectively (p=.1958), but not in the autograft groups: 622.5 + 81.0 HU versus 719.5 + 224.4 HU (p=.1347). Between group comparison of CT densitometry at each time point was significantly different at 3 months (p=.0011) but not at 6 months (p=.0963). No statistical differences were detected in stiffness and range of motion between the autograft group versus the Healos/MP52 group for any of the motions tested at either follow-up point (p>.05). There was an apparent, although not statistically different, increase in stiffness with a concomitant decrease in the range of motion, when these groups were compared with intact, nonoperative motion segments. Histologic specimens revealed endochondral bone formation within the cages and periosteal bone formation anterior to the cages. The fraction amount of trabecular bone within cages filled with Healos/MP52 was 17.3% + 5.8% at 3 months and increased to 25.1% + 9.5% in the 6-month group (p=.024), indicating progressive growth of bone.Conclusion: In this animal model of interbody fusion, a recombinant human bioactive growth factor (rhMP52) combined with a mineralized collagen matrix (Healos) produced bony fusion in and around threaded cages and in a manner superior to autograft. No pathology or aberrant bone formation was observed. Clinical evaluation of this promising combination of materials is warranted.